Bloomberg reported that Savient Pharmaceuticals sought bankruptcy protection and court approval to sell its assets to a US WorldMeds unit for $55 million.

Bloomberg said U.S. Bank is Savient’s largest unsecured creditor, according to a bankruptcy filing.

To read the entire article, click here.